The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Carbapenem-Based Antibiotics Global Market Report 2023, the carbapenem-based antibiotics market is expected to show significant growth in the forecast period.

Key insights from the carbapenem-based antibiotics market forecast include:

1. Market Size

The global carbapenem-based antibiotics market is expected to grow from $4.2 billion in 2022 to $4.43 billion in 2023 at a compound annual growth rate (CAGR) of 5.2%. The size of carbapenem-based antibiotics market is expected to reach $5.37 billion in 2027 at a CAGR of 4.9%.

2. Major Driver

The increasing incidence of bacterial infections is expected to propel the growth of the carbapenem-based antibiotics market going forward. Bacterial infections are infections caused by bacteria, microscopic organisms that can invade the body and cause a range of diseases and symptoms. Carbapenem-based antibiotics treat severe or multidrug-resistant bacterial infections, including those caused by gram-positive and gram-negative bacteria. For Instance, In November 2022, according to the report published by the UK Health Security Agency (UKHSA), an executive government agency of the Department of Health and Social Care, in England, the anticipated total number of antibiotic-resistant severe infections increased by 2.2% in 2021 compared to 2020 (53,985 vs. 52,842). Therefore, an increased incidence of bacterial infections drives the growth of the carbapenem-based antibiotics market.

View More On The Carbapenem-Based Antibiotics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/carbapenem-based-antibiotics-global-market-report

3. Key Trend

Product Innovations are the key trend gaining popularity in the carbapenem-based antibiotics market. Major companies operating in the carbapenem-based antibiotics market are innovating products to sustain their position in the market. For instance, in September 2020, Shionogi, Inc., a Japan-based discovery-based pharmaceutical company, made an announcement regarding the approval by the U.S. Food and Drug Administration (FDA) of a supplemental New Drug Application (sNDA) for FETROJA (cefiderocol). This approval allows for the treatment of patients aged 18 years and older who have hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP). The indication applies specifically to cases caused by susceptible Gram-negative microorganisms.

4. Largest Region

North America was the largest region in the Carbapenem-Based Antibiotics market in 2022.

5. Major Players

Major players in the carbapenem-based antibiotics market are Pfizer Inc., Merck & Co. Inc., Saint-Gobain S.A., Fresenius Kabi LLC, GlaxoSmithKline Plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Meiji Holdings Co. Ltd., Sandoz International GmbH, Sumitomo Dainippon Pharma Co. Ltd., Shionogi & Co Ltd., Aurobindo Pharma Ltd., Acurx Pharmaceuticals, LLC, Daewoong Pharmaceutical Co. Ltd., CeramTec GmbH, ACS Dobfar S.p.A, JW Pharmaceutical Corp, Centrient Pharmaceuticals Co, Spero Therapeutics Inc., Kopran Limited, Savior Lifetec Corporation, Amedica Corporation, Flagship Biotech International Pvt. Ltd., Iterum Therapeutics plc, Cam Carbapenem-based antibiotics BV, Intelicure Lifesciences, and Ikeda Corporation.

Request A Sample Of The Global Carbapenem-Based Antibiotics Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12035&type=smp

Key Carbapenem-Based Antibiotics Market Segments
The global carbapenem-based antibiotics market is segmented –
1) By Type: Meropenem, Imipenem, Doripenem, Tebipenem, Other Types
2) By Indication: Intra-abdominal Infections, Urinary Tract Infections, Pneumonia, Bacterial Meningitis, Skin and Skin Structure Infections, Acute Pelvic Infections, Prophylaxis of Surgical Site Infection, Respiratory Tract Infections, Gynecological Infections, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The Carbapenem-Based Antibiotics Global Market Report 2023  provides an in-depth analysis on the carbapenem-based antibiotics market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the carbapenem-based antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Antibiotics Global Market Report 2023
Pseudomonas Aeruginosa Infection Treatment Global Market Report 2023
Animal Antibiotics And Antimicrobials Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model